Variables | All (n = 57) |
---|---|
Age (years) | 65 ± 12 |
Male (%) | 78.9 |
Body mass index (kg/m2) | 24.2 ± 4.1 |
STEMI (%) | 77.2 |
Multivessel disease (%) | 35.1 |
Culprit vessel | |
 Left anterior descending artery (%) | 52.6 |
 Left circumflex coronary artery (%) | 14.0 |
 Right coronary artery (%) | 33.3 |
Current smoking (%) | 54.4 |
Hypertension (%) | 61.4 |
Diabetes mellitus (%) | 49.1 |
Lipid parameters at admission | |
 Total cholesterol (mg/dl) | 201 ± 37 |
 LDL-C (mg/dl) | 128 ± 36 |
 HDL-C (mg/dl) | 46 ± 12 |
 Triglycerides (mg/dl) | 129 ± 96 |
eGFR at admission (ml/min/1.73 m2) | 75.2 ± 18.2 |
Urinary L-FABP (μg/g creatinine) | 20.3 ± 58.0 |
hs-CRP at 7 days after admission (mg/dl) | 1.56 ± 1.72 |
Medications before admission | |
 Statin (%) | 21.1 |
 ACEI/ARB (%) | 21.1 |
 Oral anti-diabetic drugs (%) | 17.5 |
Conventional glucose indicators | |
 HbA1c at admission (%) | 6.1 ± 1.0 |
 FPGa (mg/dl) | 109 ± 17 |
 HOMA-IRa | 2.1 ± 1.4 |
CGMS parametersa | |
 Maximum blood glucose (mg/dl) | 184 ± 48 |
 Minimum blood glucose (mg/dl) | 90 ± 21 |
 Mean blood glucose (mg/dl) | 126 ± 27 |
 SD around mean blood glucose (mg/dl) | 22 ± 12 |
 MAGE (blood glucose variability) (mg/dl) | 48 ± 26 |
 Hyperglycemia ≥200 mg/dl (%) | 29.8 |
 Hypoglycemia <60 mg/dl (%) | 7.0 |